Reagent, enzyme immunohaematology

Primary use
Diagnosis / Measurement / Monitoring
Type of medical device or related product
Solutions and reagents
General vs. specific use (health condition)
General
Intended population sex
All
Level of technical knowledge
Specialized clinical
Capital
No
Reusable
No
Requirements
None
WHO list of priority medical devices
Cardiovascular diseases and diabetes (2021)
Service delivery platforms / Healthcare levels
First-level (district) hospital services
General outpatient (health post, health center) and outreach services for primary care
Second-level and third-level hospital services and specialized outpatient services
Healthcare unit
Laboratory
EMDN related code(s)
W0103030402
CONTROL KITS (IMMUNOHAEMATOLOGY)
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn
GMDN related code(s)
46175
Enzyme immunohaematology reagent IVD, control (A material intended to be used in immunohaematological testing of a clinical specimen to verify that enzyme treatment of red cells to remove sialic acid residues in order to enhance or potentiate red cell agglutination has been adequate.)
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024 
Decommissioning
WHO resources on medical devices